Oric Pharmaceuticals (ORIC)

• Market cap: $1.19B
• 1 day: -2.47%
• 5 days: -6.28%
• 1 month: -13.31%
• 3 months: 27.1%
• 6 months: 160.43%
• Year to date: 48.18%
• 1 year: 23.02%
• 5 years: -49.32%
• 10 years: -52.5%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 128